Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized Trial

PURPOSE: HER2 is overexpressed more frequently in ductal carcinoma in situ (DCIS) than in invasive breast cancer but its prognostic significance and predictive role for radiotherapy has not been clearly established. We investigated the prognostic and predictive value of HER2 overexpression in DCIS....

Descripción completa

Detalles Bibliográficos
Autores principales: Thorat, Mangesh A., Levey, Pauline M., Jones, J. Louise, Pinder, Sarah E., Bundred, Nigel J., Fentiman, Ian S., Cuzick, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2021
Materias:
Precision Medicine and Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612534/
https://www.ncbi.nlm.nih.gov/pubmed/34380636
http://dx.doi.org/10.1158/1078-0432.CCR-21-1239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612534/
https://www.ncbi.nlm.nih.gov/pubmed/34380636
http://dx.doi.org/10.1158/1078-0432.CCR-21-1239

Ejemplares similares